Logo
Home
About
Articles
FAQ
Sign In
Search
Join the mailing list
Women's Health

Round Up: A Tale of Two Health Systems, a Wave of Health-Tech News, and a Four Questions with Co-founder & CEO of Ambience

As Americans juggle cash-pay care and high-deductible insurance, companies like Aidoc, Datavant, and Prosper AI are testing whether tech can ease the pressure.

Christina Farr, +1
Oct 2, 2025
Round Up: A Tale of Two Health Systems, a Wave of Health-Tech News, and a Four Questions with Co-founder & CEO of Ambience

Let’s banish the term “worried well”

Plus, a review of Prenuvo’s enhanced screening

Christina Farr
Sep 25, 2025
Let’s banish the term “worried well”

Roundup: The Return of Deals, the Rise of Wellness, and AI’s Coming Regulation

As startups chase hot markets like GLP-1s and testosterone, the Trump Administration continues to push on wellness - and not always with the evidence to back it up. Deals are finally ramping up (and why). Plus a “Four Questions with” interview with digital health OG Halle Tecco!

Christina Farr, +1
Sep 23, 2025
Roundup: The Return of Deals, the Rise of Wellness, and AI’s Coming Regulation

Roundup: Testing Healthcare AI in Space, Increasing Statin Adoption, Epic's move into Scribing, etc

Plus Peloton's surprise profit, 4 Questions with the CSO of Solera Health and a hot-take on AI driven automation.

Christina Farr, +1
Aug 14, 2025
Roundup: Testing Healthcare AI in Space, Increasing Statin Adoption, Epic's move into Scribing, etc

The massive opportunity in women's longevity

State of the union, and where we go from here

Leslie Schrock
Feb 6, 2025
The massive opportunity in women's longevity

Why is it still so hard to succeed in women's health?

One longtime women's health investor weighs in...

Leslie Schrock
Oct 15, 2024
Why is it still so hard to succeed in women's health?

An OB Gyn's view of the menopause market

Not all companies (or hormones) are created equal

Christina Farr
Aug 22, 2024
An OB Gyn's view of the menopause market

A few unfiltered thoughts on Flo, the $1 billion period-tracking app

The valuation may seem crazy, but it's actually not...

Christina Farr
Jul 31, 2024
A few unfiltered thoughts on Flo, the $1 billion period-tracking app

Interested in sponsoring Second Opinion?
Reach out!

I consent to receive newsletters via email. Sign up Terms of service.